Xylyx Bio is harnessing the power of tissue-specific extracellular matrix for applications in drug discovery and screening, in vitro disease models, and more. By bringing the native in-vivo environment to the in-vitro setting, Xylyx Bio’s tissue-specific ECM substrates support disease models that are significantly more predictive of human physiology, thus facilitating acceleration of drug discovery and development. We are committed to providing scientists with biomimetic solutions that transform the way biomedical research is conducted.